Skip to main content
. Author manuscript; available in PMC: 2018 Jan 5.
Published in final edited form as: Eur J Med Chem. 2016 Sep 18;125:515–527. doi: 10.1016/j.ejmech.2016.09.053

Table 1.

E. coli topoisomerase I inhibition and whole cell antibacterial activities (µM) of fluoroquinophenoxazine derivativesa

Topoisomerase inhibitory activity (IC50, µM) Whole cell based antibacterial activity (MIC, µM)

Compd E. coli
topo I
(type IA)
E. coli
DNA gyrase
(type IIA)
Human
topo I
(type IB)
Human
topo IIα
(type IIA)
E. coli
Imp4213
(BAS3023)
E. coli
(MG1655)
WT
B. subtilis
(ATCC 6633)
WT
M
tuberculosis
(H37Rv)
Vero cell
IC50
SIb
1 1.95 >125 31.3 >500 0.78–1.56 >200 6.25 11.2 75.7 6.8
6a 15.6 50 >200 25
6b 31.25 >200 >200 200
6c >125 >200 >200 >200
7a 15.6 0.78 200 12.5
7b 31.25 200 >200 >200
7c >125 >200 >200 25
7d 15.6 >200 >200 >200
7e 31.25 62.5 31.25 125 0.39 50 3.12 29 >127 >4.4
9 1.95 25 >200 50
10a 1.95 62.5–125 31.25 250–500 1.56 100 0.78 19 95 5.0
10b 3.9 >200 >200 >200
11a 0.48 15.6–31.25 15.6 3.9–7.8 0.78 6.25 0.78 7.6 29 3.8
11b 0.24 7.8–15.6 7.8 1.95–3.9 0.39 >200 25 29.5 >126 >4.3
11c 3.9 3.12 >200 0.78
11d 0.97 7.8 15.6 15.6 0.19–0.39 >200 0.19 3.5 24.7 7.1
11e 3.9 50 >200 25–50
11f 3.9–7.8 3.12 >200 12.5 38.4 30.7 0.8
11g 0.48 15.6 3.9 1.95–3.9 0.39–0.78 >200 1.56 2.5 24.4 9.8
11h 0.97 15.6–31.25 7.8–15.6 3.9–7.8 0.78 >200 1.56 21.6 43.0 2.0
11i 3.9 25 >200 12.5
11j 3.9 25 >200 12.5
11k 15.6 >200 >200 >200
12 7.8 >200 >200 >200
15a 3.9 12.5 >200 12.5
16 0.48 3.9 7.8 1.95–3.9 1.56 >200 0.78 >50 >50
17a 0.48–0.97 3.9 3.9 0.97–1.95 1.56 >200 6.25 >63.1 >63.1
17b 0.48–0.97 3.9 3.9 3.9 6.25 >200 12.5 >63.1 >63.1
a

Blank cells indicate Not Determined.

b

Selectivity index = cytotoxic IC50 against Vero cells/MIC against M. tuberculosis.